BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Huaier Granule readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Huaier Granule\, from ClinicalTrials.gov 
 estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07358520-2137@assetmemo.bio
DTSTAMP:20261121T010140Z
DTSTART;VALUE=DATE:20270128
DTEND;VALUE=DATE:20270129
SUMMARY:Huaier Granule: Phase 4 readout est. (NCT07358520)
DESCRIPTION:Huaier Granule\, phase 4.\nStudy: Clinical Study on the Use of 
 Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab an
 d Anlotinib in Lung Cancer Patients\nEstimated primary completion: 28 Janu
 ary 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout 
 date\, and it can move.\nDrug page: https://assetmemo.bio/drug/huaier-gran
 ule#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT
 07358520
URL:https://assetmemo.bio/drug/huaier-granule#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07413354-2137@assetmemo.bio
DTSTAMP:20261121T010140Z
DTSTART;VALUE=DATE:20270331
DTEND;VALUE=DATE:20270401
SUMMARY:Huaier Granule: Phase 2 readout est. (NCT07413354)
DESCRIPTION:Huaier Granule\, phase 2.\nStudy: Tislelizumab Combined With Hu
 aier Granule as First-line Treatment for Unresectable Hepatocellular Carci
 noma\nEstimated primary completion: 31 March 2027. This is a ClinicalTrial
 s.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pag
 e: https://assetmemo.bio/drug/huaier-granule#upcoming-events\nRegistry rec
 ord: https://clinicaltrials.gov/study/NCT07413354
URL:https://assetmemo.bio/drug/huaier-granule#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05839314-2137@assetmemo.bio
DTSTAMP:20261121T010140Z
DTSTART;VALUE=DATE:20270503
DTEND;VALUE=DATE:20270504
SUMMARY:Huaier Granule: Phase 4 readout est. (NCT05839314)
DESCRIPTION:Huaier Granule\, phase 4.\nStudy: Effect of Huaier Granule on t
 he Treatment of Idiopathic Membranous Nephropathy\nEstimated primary compl
 etion: 3 May 2027. This is a ClinicalTrials.gov estimate\, not a confirmed
  readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/hu
 aier-granule#upcoming-events\nRegistry record: https://clinicaltrials.gov/
 study/NCT05839314
URL:https://assetmemo.bio/drug/huaier-granule#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07355361-2137@assetmemo.bio
DTSTAMP:20261121T010140Z
DTSTART;VALUE=DATE:20270615
DTEND;VALUE=DATE:20270616
SUMMARY:Huaier Granule: Phase 2 readout est. (NCT07355361)
DESCRIPTION:Huaier Granule\, phase 2.\nStudy: Huaier Granule and Proteinuri
 a\nEstimated primary completion: 15 June 2027. This is a ClinicalTrials.go
 v estimate\, not a confirmed readout date\, and it can move.\nDrug page: h
 ttps://assetmemo.bio/drug/huaier-granule#upcoming-events\nRegistry record:
  https://clinicaltrials.gov/study/NCT07355361
URL:https://assetmemo.bio/drug/huaier-granule#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06090994-2137@assetmemo.bio
DTSTAMP:20261121T010140Z
DTSTART;VALUE=DATE:20270731
DTEND;VALUE=DATE:20270801
SUMMARY:Huaier Granule: Phase 4 readout est. (NCT06090994)
DESCRIPTION:Huaier Granule\, phase 4.\nStudy: Prevention of Recurrence and 
 Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Mono
 therapy\nEstimated primary completion: July 2027. This is a ClinicalTrials
 .gov estimate\, not a confirmed readout date\, and it can move.\nDrug page
 : https://assetmemo.bio/drug/huaier-granule#upcoming-events\nRegistry reco
 rd: https://clinicaltrials.gov/study/NCT06090994
URL:https://assetmemo.bio/drug/huaier-granule#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT04790305-2137@assetmemo.bio
DTSTAMP:20261121T010140Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:Huaier Granule: Phase 4 readout est. (NCT04790305)
DESCRIPTION:Huaier Granule\, phase 4.\nStudy: Effect of Huaier Granule on A
 djuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer\
 nEstimated primary completion: 31 December 2027. This is a ClinicalTrials.
 gov estimate\, not a confirmed readout date\, and it can move.\nDrug page:
  https://assetmemo.bio/drug/huaier-granule#upcoming-events\nRegistry recor
 d: https://clinicaltrials.gov/study/NCT04790305
URL:https://assetmemo.bio/drug/huaier-granule#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06387368-2137@assetmemo.bio
DTSTAMP:20261121T010140Z
DTSTART;VALUE=DATE:20280331
DTEND;VALUE=DATE:20280401
SUMMARY:Huaier Granule: Phase 4 readout est. (NCT06387368)
DESCRIPTION:Huaier Granule\, phase 4.\nStudy: Clinical Study of Huaier Gran
 ule in the Treatment of Unresectable Pancreatic Cancer\nEstimated primary 
 completion: March 2028. This is a ClinicalTrials.gov estimate\, not a conf
 irmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/dr
 ug/huaier-granule#upcoming-events\nRegistry record: https://clinicaltrials
 .gov/study/NCT06387368
URL:https://assetmemo.bio/drug/huaier-granule#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07197853-2137@assetmemo.bio
DTSTAMP:20261121T010140Z
DTSTART;VALUE=DATE:20280630
DTEND;VALUE=DATE:20280701
SUMMARY:Huaier Granule: Phase 3 readout est. (NCT07197853)
DESCRIPTION:Huaier Granule\, phase 3\, Non-Small Cell Lung Cancer.\nStudy: 
 Clinical Efficacy and Safety of Microwave Ablation Combined With Huaier Gr
 anules in Patients With Inoperable Stage IA Non-Small Cell Lung Cancer: A 
 Prospective\, Single-Center\, Randomized Controlled Clinical Trial\nEstima
 ted primary completion: 30 June 2028. This is a ClinicalTrials.gov estimat
 e\, not a confirmed readout date\, and it can move.\nDrug page: https://as
 setmemo.bio/drug/huaier-granule#upcoming-events\nRegistry record: https://
 clinicaltrials.gov/study/NCT07197853
URL:https://assetmemo.bio/drug/huaier-granule#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05498766-2137@assetmemo.bio
DTSTAMP:20261121T010140Z
DTSTART;VALUE=DATE:20290701
DTEND;VALUE=DATE:20290702
SUMMARY:Huaier Granule: Phase 4 readout est. (NCT05498766)
DESCRIPTION:Huaier Granule\, phase 4.\nStudy: Effect and Safety of Huaier G
 ranule Versus SOX Regimen in Gastric Cancer Patients\nEstimated primary co
 mpletion: 1 July 2029. This is a ClinicalTrials.gov estimate\, not a confi
 rmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/dru
 g/huaier-granule#upcoming-events\nRegistry record: https://clinicaltrials.
 gov/study/NCT05498766
URL:https://assetmemo.bio/drug/huaier-granule#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
